CRISPR Therapeutics to present clinical data at ACR Convergence 2026
The company said it will present clinical data on zugocabtagene geleucel (Zugo-cel) in autoimmune disease at the American College of Rheumatology Convergence 2026.
The company said it will present clinical data on zugocabtagene geleucel (Zugo-cel) in autoimmune disease at the American College of Rheumatology Convergence 2026.